Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-03-30FDA Approved: PRIMIDONE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Primidone (PRIMIDONE) from Actavis Pharma, Inc. The action indicates regulatory approval under t…
-
FDA approval · 2011-03-30FDA Approved: GABAPENTIN — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for gabapentin from Amneal Pharmaceuticals LLC. This entry reflects a supplemental approval of a gen…
-
FDA approval · 2011-03-29FDA Approved: PRIMIDONE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Primidone from Amneal Pharmaceuticals LLC.
-
FDA approval · 2011-03-29FDA Approved: PRIMIDONE — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved a supplemental application for Primidone submitted by Oxford Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2011-03-17Clinical Trial Update: Multicenter Trial for Adults With Partial Seizures [Phase 2]
Phase 2 multicenter trial in adults with partial seizures (epilepsy) sponsored by Teva; the study status is completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-03-08Clinical Trial Update: Transcutaneous Non-invasive Stimulation of the Vagus Nerve for the Treatment of Difficult-to-treat Epilepsy [NA]
This entry notes the completion of a clinical trial evaluating transcutaneous non-invasive vagus nerve stimulation for difficult-to-treat ep…
-
FDA approval · 2011-03-03FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tegretol (carbamazepine) from Novartis Pharmaceuticals Corporation, authorizing changes to the p…
-
FDA approval · 2011-03-03FDA Approved: TRILEPTAL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for TRILEPTAL (oxcarbazepine) from Novartis Pharmaceuticals Corporation.
-
FDA approval · 2011-03-01FDA Approved: NEURONTIN — Supplemental Application (Parke-Davis Div of Pfizer Inc)
The FDA approved a supplemental application for Neurontin (gabapentin) from the Parke-Davis Division of Pfizer Inc, resulting in an updated …
-
FDA approval · 2011-02-25FDA Approved: FLUDEOXYGLUCOSE F 18 — Original Application (PETNET Solutions, Inc.)
The FDA approved an original application for Fludeoxyglucose F-18 (FDG F-18) as a radiopharmaceutical for PET imaging, submitted by PETNET S…
-
CLINICAL_TRIALS trial_result · 2011-02-25Clinical Trial Update: Open-label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy [Phase 2]
An open-label Phase 2 study evaluating intravenous levetiracetam in children aged 1 month to 4 years with epilepsy has completed and posted …
-
CLINICAL_TRIALS trial_result · 2011-02-25Clinical Trial Update: Open-label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy [Phase 2]
An open-label Phase 2 study evaluating intravenous levetiracetam in children aged 4-16 with epilepsy; results were posted in 2011.
-
FDA approval · 2011-02-18FDA Approved: GABAPENTIN — Original Application (BioComp Pharma, Inc.)
FDA approved BioComp Pharma, Inc.'s original application for gabapentin, granting generic status and permission to market the product. Gabap…
-
FDA approval · 2011-02-11FDA Approved: GABAPENTIN — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approves Zydus Pharmaceuticals USA Inc.'s Gabapentin under an original ANDA, authorizing a generic gabapentin product.
-
FDA approval · 2011-01-27FDA Approved: PHENYTOIN SODIUM — Supplemental Application (Acella Pharmaceuticals, LLC)
The FDA approved a supplemental application for Phenytoin Sodium submitted by Acella Pharmaceuticals, LLC.
-
FDA approval · 2011-01-25FDA Approved: VALPROIC ACID — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Valproic acid submitted by Bionpharma Inc.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Heart Rate Changes During Normal Activity, Exercise, and Sleep in Normal Healthy Subjects With and Without Epilepsy
This completed trial evaluated heart rate changes during rest, exercise, and sleep in healthy subjects, comparing those with epilepsy to tho…
-
FDA approval · 2011-01-21FDA Approved: DIVALPROEX SODIUM — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for divalproex sodium submitted by NorthStar Rx LLC.
-
CLINICAL_TRIALS research · 2011-01-19Clinical Trial Update: Modified Atkins Diet in Children and Adolescents With Drug-resistant Epilepsy [NA]
This update notes the completion of a clinical trial evaluating the Modified Atkins Diet in children and adolescents with drug-resistant epi…
-
FDA approval · 2011-01-18FDA Approved: SABRIL — Supplemental Application (Lundbeck Pharmaceuticals LLC)
FDA approved a supplemental application for Sabril (vigabatrin) submitted by Lundbeck Pharmaceuticals LLC.
-
FDA approval · 2011-01-18FDA Approved: SABRIL — Supplemental Application (Lundbeck Pharmaceuticals LLC)
FDA approved a supplemental application for Sabril (vigabatrin) submitted by Lundbeck Pharmaceuticals LLC.
-
FDA approval · 2011-01-17FDA Approved: DILANTIN-125 — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for DILANTIN-125 (phenytoin) from Viatris Specialty LLC, reflecting an approved addition/modificatio…
-
FDA approval · 2011-01-13FDA Approved: LAMOTRIGINE — Original Application (Alembic Pharmaceuticals Limited)
FDA approves Alembic Pharmaceuticals Limited's generic lamotrigine under an Original Application for marketing in the United States. This ap…
-
FDA approval · 2011-01-12FDA Approved: LAMOTRIGINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Lamotrigine from Dr. Reddy's Laboratories Limited, advancing the approval status of its generic …
-
FDA approval · 2011-01-10FDA Approved: GABAPENTIN — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for gabapentin from Aurobindo Pharma Limited, marking a supplemental approval for this generic g…